Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.

Couret C, Poinas A, Volteau C, Riche VP, Le Lez ML, Errera MH, Creuzot-Garcher C, Baillif S, Kodjikian L, Ivan C, Le Jumeau de Kergaradec LM, Chiffoleau A, Jobert A, Jaulin J, Biron L, Hervouet E, Weber M.

Trials. 2020 Feb 10;21(1):159. doi: 10.1186/s13063-020-4066-0.

2.

Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes.

Peixoto P, Grandvallet C, Feugeas JP, Guittaut M, Hervouet E.

Cells. 2019 Dec 17;8(12). pii: E1656. doi: 10.3390/cells8121656. Review.

3.

EMT is associated with an epigenetic signature of ECM remodeling genes.

Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, Hendrick E, Delage-Mourroux R, Mosser J, Borg C, Feugeas JP, Herfs M, Boyer-Guittaut M, Hervouet E.

Cell Death Dis. 2019 Feb 27;10(3):205. doi: 10.1038/s41419-019-1397-4.

4.

ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes.

Claude-Taupin A, Fonderflick L, Gauthier T, Mansi L, Pallandre JR, Borg C, Perez V, Monnien F, Algros MP, Vigneron M, Adami P, Delage-Mourroux R, Peixoto P, Herfs M, Boyer-Guittaut M, Hervouet E.

Cells. 2018 Dec 6;7(12). pii: E248. doi: 10.3390/cells7120248.

5.

The Promising Role of New Generation HDACis in Anti-Cancer Therapies.

Hervouet E.

EBioMedicine. 2018 Jun;32:6-7. doi: 10.1016/j.ebiom.2018.05.014. Epub 2018 May 11. No abstract available.

6.

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma.

Asgarova A, Asgarov K, Godet Y, Peixoto P, Nadaradjane A, Boyer-Guittaut M, Galaine J, Guenat D, Mougey V, Perrard J, Pallandre JR, Bouard A, Balland J, Tirole C, Adotevi O, Hendrick E, Herfs M, Cartron PF, Borg C, Hervouet E.

Oncoimmunology. 2018 Feb 1;7(5):e1423170. doi: 10.1080/2162402X.2017.1423170. eCollection 2018.

7.

Circulating cell-free DNA in patients with alveolar echinococcosis.

Baraquin A, Hervouet E, Richou C, Flori P, Peixoto P, Azizi A, Delabrousse E, Blagosklonov O, Umhang G, Bresson-Hadni S, Valot B, Grenouillet F; EchinoVista study group.

Mol Biochem Parasitol. 2018 Jun;222:14-20. doi: 10.1016/j.molbiopara.2018.04.004. Epub 2018 Apr 18.

PMID:
29679605
8.

Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma.

Hervouet E, Peixoto P, Delage-Mourroux R, Boyer-Guittaut M, Cartron PF.

Clin Epigenetics. 2018 Feb 9;10:17. doi: 10.1186/s13148-018-0450-y. eCollection 2018. Review.

9.

GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells.

Poillet-Perez L, Jacquet M, Hervouet E, Gauthier T, Fraichard A, Borg C, Pallandre JR, Gonzalez BJ, Ramdani Y, Boyer-Guittaut M, Delage-Mourroux R, Despouy G.

Oncotarget. 2017 Jul 27;8(34):55998-56020. doi: 10.18632/oncotarget.19639. eCollection 2017 Aug 22.

10.

Carbon nanotubes as gene carriers: Focus on internalization pathways related to functionalization and properties.

Caoduro C, Hervouet E, Girard-Thernier C, Gharbi T, Boulahdour H, Delage-Mourroux R, Pudlo M.

Acta Biomater. 2017 Feb;49:36-44. doi: 10.1016/j.actbio.2016.11.013. Epub 2016 Nov 5. Review.

PMID:
27826000
11.

Nanovectorization of DNA Through Cells Using Protamine Complexation.

Boukari K, Caoduro C, Kacem R, Skandrani N, Borg C, Boulahdour H, Gharbi T, Delage-Mourroux R, Hervouet E, Pudlo M, Picaud F.

J Membr Biol. 2016 Aug;249(4):493-501. doi: 10.1007/s00232-016-9890-5. Epub 2016 Mar 24.

PMID:
27010822
12.

The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models.

Hervouet E, Claude-Taupin A, Gauthier T, Perez V, Fraichard A, Adami P, Despouy G, Monnien F, Algros MP, Jouvenot M, Delage-Mourroux R, Boyer-Guittaut M.

BMC Cancer. 2015 Oct 17;15:729. doi: 10.1186/s12885-015-1761-4.

13.

Proximity Ligation In situ Assay is a Powerful Tool to Monitor Specific ATG Protein Interactions following Autophagy Induction.

Gauthier T, Claude-Taupin A, Delage-Mourroux R, Boyer-Guittaut M, Hervouet E.

PLoS One. 2015 Jun 2;10(6):e0128701. doi: 10.1371/journal.pone.0128701. eCollection 2015.

14.

Use of epigenetic modulators as a powerful adjuvant for breast cancer therapies.

Claude-Taupin A, Boyer-Guittaut M, Delage-Mourroux R, Hervouet E.

Methods Mol Biol. 2015;1238:487-509. doi: 10.1007/978-1-4939-1804-1_25. Review.

PMID:
25421676
15.

The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures.

Pacaud R, Brocard E, Lalier L, Hervouet E, Vallette FM, Cartron PF.

Sci Rep. 2014 Mar 18;4:4230. doi: 10.1038/srep04230.

16.

Antioxidants delay clinical signs and systemic effects of ENU induced brain tumors in rats.

Hervouet E, Staehlin O, Pouliquen D, Debien E, Cartron PF, Menanteau J, Vallette FM, Olivier C.

Nutr Cancer. 2013;65(5):686-94. doi: 10.1080/01635581.2013.789541.

PMID:
23859036
17.

Epigenetic regulation of estrogen signaling in breast cancer.

Hervouet E, Cartron PF, Jouvenot M, Delage-Mourroux R.

Epigenetics. 2013 Mar;8(3):237-45. doi: 10.4161/epi.23790. Epub 2013 Jan 30. Review.

18.

HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression.

Cartron PF, Blanquart C, Hervouet E, Gregoire M, Vallette FM.

Mol Oncol. 2013 Jun;7(3):452-63. doi: 10.1016/j.molonc.2012.11.004. Epub 2012 Dec 21.

19.

DNA methylation and apoptosis resistance in cancer cells.

Hervouet E, Cheray M, Vallette FM, Cartron PF.

Cells. 2013 Jul 18;2(3):545-73. doi: 10.3390/cells2030545.

20.

Kinetics of DNA methylation inheritance by the Dnmt1-including complexes during the cell cycle.

Hervouet E, Nadaradjane A, Gueguen M, Vallette FM, Cartron PF.

Cell Div. 2012 Feb 20;7:5. doi: 10.1186/1747-1028-7-5.

21.

Folate supplementation limits the tumourigenesis in rodent models of gliomagenesis.

Cartron PF, Hervouet E, Debien E, Olivier C, Pouliquen D, Menanteau J, Loussouarn D, Martin SA, Campone M, Vallette FM.

Eur J Cancer. 2012 Oct;48(15):2431-41. doi: 10.1016/j.ejca.2012.01.002. Epub 2012 Feb 8.

PMID:
22325970
22.

In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression.

Bourseau-Guilmain E, Lemaire L, Griveau A, Hervouet E, Vallette F, Berger F, Menei P, Benoit JP, Wion D, Garcion E.

Int J Oncol. 2012 Apr;40(4):1220-9. doi: 10.3892/ijo.2011.1271. Epub 2011 Nov 23.

23.

ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients.

Debien E, Hervouet E, Gautier F, Juin P, Vallette FM, Cartron PF.

Clin Epigenetics. 2011 Aug;2(2):369-381. Epub 2011 May 15.

24.

Proximity ligation in situ assay for monitoring the global DNA methylation in cells.

Hervouet E, Hulin P, Vallette FM, Cartron PF.

BMC Biotechnol. 2011 Apr 6;11:31. doi: 10.1186/1472-6750-11-31.

25.

Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells.

Hervouet E, Lalier L, Debien E, Cheray M, Geairon A, Rogniaux H, Loussouarn D, Martin SA, Vallette FM, Cartron PF.

PLoS One. 2010 Jun 29;5(6):e11333. doi: 10.1371/journal.pone.0011333.

26.

Dnmt1/Transcription factor interactions: an alternative mechanism of DNA methylation inheritance.

Hervouet E, Vallette FM, Cartron PF.

Genes Cancer. 2010 May;1(5):434-43. doi: 10.1177/1947601910373794.

27.
28.

Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation.

Hervouet E, Vallette FM, Cartron PF.

Epigenetics. 2009 Oct 1;4(7):487-99. Epub 2009 Oct 21.

PMID:
19786833
29.

Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation.

Hervouet E, Debien E, Campion L, Charbord J, Menanteau J, Vallette FM, Cartron PF.

Clin Cancer Res. 2009 May 15;15(10):3519-29. doi: 10.1158/1078-0432.CCR-08-2062.

30.

Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members.

Gallenne T, Gautier F, Oliver L, Hervouet E, Noël B, Hickman JA, Geneste O, Cartron PF, Vallette FM, Manon S, Juin P.

J Cell Biol. 2009 Apr 20;185(2):279-90. doi: 10.1083/jcb.200809153.

31.

HIF and reactive oxygen species regulate oxidative phosphorylation in cancer.

Hervouet E, Cízková A, Demont J, Vojtísková A, Pecina P, Franssen-van Hal NL, Keijer J, Simonnet H, Ivánek R, Kmoch S, Godinot C, Houstek J.

Carcinogenesis. 2008 Aug;29(8):1528-37. doi: 10.1093/carcin/bgn125. Epub 2008 May 29.

PMID:
18515279
32.

Dietary prevention of malignant glioma aggressiveness, implications in oxidant stress and apoptosis.

Pouliquen D, Olivier C, Hervouet E, Pedelaborde F, Debien E, Le Cabellec MT, Gratas C, Homma T, Meflah K, Vallette FM, Menanteau J.

Int J Cancer. 2008 Jul 15;123(2):288-295. doi: 10.1002/ijc.23513.

33.

Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.

Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M, Mège-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H.

Hum Mol Genet. 2008 Apr 1;17(7):986-95. Epub 2007 Dec 21.

PMID:
18156159
34.

Actuality of Warburg's views in our understanding of renal cancer metabolism.

Godinot C, de Laplanche E, Hervouet E, Simonnet H.

J Bioenerg Biomembr. 2007 Jun;39(3):235-41. Review.

PMID:
17665292
35.

Mitochondria and reactive oxygen species in renal cancer.

Hervouet E, Simonnet H, Godinot C.

Biochimie. 2007 Sep;89(9):1080-8. Epub 2007 Mar 19. Review.

PMID:
17466430
36.

Mitochondrial disorders in renal tumors.

Hervouet E, Godinot C.

Mitochondrion. 2006 Jun;6(3):105-17. Epub 2006 Apr 21. Review.

PMID:
16714150
37.

Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride.

Hervouet E, Pecina P, Demont J, Vojtísková A, Simonnet H, Houstek J, Godinot C.

Biochem Biophys Res Commun. 2006 Jun 16;344(4):1086-93. Epub 2006 Apr 19.

PMID:
16643849
38.

Pathogenicity of missense mutations in SURF1 deficiency inducing the Leigh syndrome. Importance in diagnosis.

Dubot A, Hervouet E, Mandon G, Zabot MT, Godinot C.

Mitochondrion. 2004 Jun;4(1):41-7.

PMID:
16120373
39.

A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis.

Hervouet E, Demont J, Pecina P, Vojtísková A, Houstek J, Simonnet H, Godinot C.

Carcinogenesis. 2005 Mar;26(3):531-9. Epub 2004 Dec 16.

PMID:
15604095

Supplemental Content

Loading ...
Support Center